Sinco Pharmaceuticals Holdings Ltd.

  • Market Cap: N/A
  • Industry: Retailing
  • ISIN: KYG8154Y1052
  • HKG: 6833
HKD
0.14
-0.05 (-27.98%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Sinco Pharmaceuticals Holdings Ltd.
Shanghai Haohai Biological Technology Co., Ltd.
Shanghai Pioneer Holding Ltd.
Meilleure Health International Industry Group Ltd.
IVD Medical Holding Ltd.
China Health Group Ltd.
Cryofocus Medtech (Shanghai) Co. Ltd.
Kingworld Medicines Group Ltd.
Tycoon Group Holdings Ltd.
Yestar Healthcare Holdings Co. Ltd.
Guanze Medical Information Industry (Holding) Co., Ltd.

Why is Sinco Pharmaceuticals Holdings Ltd. ?

1
High Debt company with Weak Long Term Fundamental Strength
  • The company is Net-Debt Free
2
Flat results in Jun 26
  • ROCE(HY) Lowest at 4.35%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 2.48 times
  • INVENTORY TURNOVER RATIO(HY) Lowest at 5.56 times
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -40.77% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sinco Pharmaceuticals Holdings Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Sinco Pharmaceuticals Holdings Ltd.
-100.0%
-0.80
55.66%
Hang Seng Hong Kong
-5.07%
-0.26
18.70%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-0.54%
EBIT Growth (5y)
-13.15%
EBIT to Interest (avg)
5.55
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.08
Sales to Capital Employed (avg)
2.61
Tax Ratio
27.60%
Dividend Payout Ratio
8.98%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
52.46%
ROE (avg)
26.01%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
0.42
EV to EBIT
4.90
EV to EBITDA
3.65
EV to Capital Employed
0.47
EV to Sales
0.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.57%
ROE (Latest)
4.87%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -4.84% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -19.61 %

-6What is not working for the Company
ROCE(HY)

Lowest at 4.35%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.48 times

INVENTORY TURNOVER RATIO(HY)

Lowest at 5.56 times

Here's what is working for Sinco Pharmaceuticals Holdings Ltd.

Debt-Equity Ratio
Lowest at -19.61 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -4.84% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at HKD 18.4 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation
At HKD 18.4 MM has Grown at 55.75%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for Sinco Pharmaceuticals Holdings Ltd.

Debtors Turnover Ratio
Lowest at 2.48 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Inventory Turnover Ratio
Lowest at 5.56 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Footer loading